Clinical trial
Paclitaxel and Capecitabine in Patients With Metastatic/Recurrence Esophageal…
NCT00453323 · National Cancer Center, Korea, Other · Unknown status
Key facts
| NCT number | NCT00453323 |
|---|---|
| Title | Paclitaxel and Capecitabine in Patients With Metastatic/Recurrence Esophageal Cancer |
| Official title | A Phase II Study of Weekly Paclitaxel and Capecitabine in Patients With Metastatic or Recurrent Esophageal Cancer |
| Lead sponsor | National Cancer Center, Korea, Other |
| Status | Unknown status |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Esophageal Cancer |
| Intervention type | Drug |
| Interventions | Paclitaxel, Capecitabine |
| Enrollment | 33 |
| Start date | Jun 1, 2006 |
| Primary completion | Dec 1, 2009 |
| Completion | Dec 1, 2010 |
| First posted | Mar 28, 2007 |
| Last update posted | Jul 12, 2010 |
| Countries | South Korea |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: